Kalium-Natrium-Glucose Braun

Potassium chloride, sodium chloride and glucose monohydrate, the active ingredients in Kalium-Natrium-Glucose Braun, are an electrolyte solution presented as an injection solution for intravenous or subcutaneous use. It is used to replace electrolytes and provide metabolic energy in patients with electrolyte disturbances, dehydration or after surgery.

GNH USA supplies Kalium-Natrium-Glucose Braun as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Kalium-Natrium-Glucose Braun is an electrolyte solution used in conditions that require restoration of potassium, sodium and glucose levels. - Electrolyte replacement: restores deficient potassium, sodium and glucose in patients with fluid loss. - Hypokalemia: raises low serum potassium concentrations. - Hyponatremia: corrects low serum sodium levels. - Dehydration: supplies essential electrolytes and energy during rehydration. - Post‑operative fluid therapy: maintains electrolyte balance after surgery.

Kalium-Natrium-Glucose Braun may cause a range of adverse reactions.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Erythema: localized redness around the injection area. - Mild hyperkalemia: slight elevation of serum potassium. - Mild hypernatremia: slight elevation of serum sodium. - Nausea: transient feeling of queasiness. - Headache: mild to moderate head discomfort.

Serious or Rare Side Effects: - Severe hyperkalemia: significant potassium rise leading to cardiac arrhythmia. - Cardiac arrhythmia: irregular heart rhythm potentially life‑threatening. - Anaphylaxis: severe allergic reaction with respiratory compromise. - Severe hypernatremia: marked sodium increase causing neurological symptoms. - Metabolic acidosis: disturbance in acid‑base balance. - Thrombophlebitis: inflammation of a vein with clot formation.

Before administering Kalium-Natrium-Glucose Braun, consider the following precautions. - Assess electrolyte levels: verify baseline potassium and sodium concentrations. - Monitor cardiac rhythm: observe for arrhythmias during and after infusion. - Adjust for renal impairment: reduce dose or infusion rate in patients with reduced kidney function. - Use caution in heart failure: avoid rapid volume expansion. - Avoid rapid infusion: administer at recommended rate to prevent electrolyte shifts. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kalium-Natrium-Glucose Braun can interact with other medications affecting electrolyte balance.

Major Interactions (Avoid): - ACE inhibitors: may potentiate hyperkalemia. - Potassium‑sparing diuretics: increase risk of elevated potassium levels. - NSAIDs: can reduce renal clearance of electrolytes. - IV calcium gluconate: may precipitate when mixed. - Digoxin: heightened risk of toxicity with electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Insulin: enhances cellular uptake of potassium, may require dose adjustment. - Beta‑blockers: can mask signs of hypoglycemia. - Loop diuretics: may cause additional electrolyte loss. - Corticosteroids: influence sodium retention. - Anticoagulants: monitor for bleeding if infusion causes vein irritation.